Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization

Hepatology

Volumn 30, Issue 2, 1999, Pages 395-400

  Kim, W Ray ^a,d   Wiesner, Russell H ^a   Poterucha, John J ^a   Therneau, Terry M ^a   Malinchoc, Michael ^a   Benson, Joanne T ^a   Crippin, Jeffrey S ^b   Klintmalm, Goran B G ^b   Rakela, Jorge ^c   Starzl, Thomas E ^c   Krom, Ruud A F ^a   Evans, Roger W ^a   Dickson, E Rolland ^a  

^a MAYO CLINIC   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d Division of Primary Care Internal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SURVIVAL TIME;

ADULT; AGED; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REOPERATION; SURVIVAL RATE; TIME FACTORS;

EID: 0032811404     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300210     Document Type: Article

References (24)

1. Belle SH, Beringer KC, Detre KM. Trends in liver transplantation in the United States. In: Terasaki PI, ed. Clinical Transplants. 1993:19-35.
2. D'Alessandro AM, Ploef RJ, Knechtle SJ, Pirsch JD, Stegall MD, Hoffmann R, Sollinger HW, et al. Retransplantation of the liver - a seven year experience. Transplantation 1993;55:1083-1087.
3. 1997 Annual report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network-Transplant Data: 1988-1996. UNOS, Richmond, VA, and the Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD.
4. Ubel PA, Arnold RM, Caplan AL. Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. JAMA 1993;270:2469-2474.
5. Powelson JA, Cosimi AB, Lewis WD, Rohrer RJ, Freeman RB, Vacanti JP, Jonas M, et al. Hepatic retransplantation in New England - a regional experience and survival model. Transplantation 1993;55:802-806.
6. Evans RW. A cost-outcome analysis of retransplantation: the need for accountability. Transplant Rev 1993;7:163-175.
7. Ricci P, Therneau TM, Malinchoc M, Benson JT, Petz J, Klintmalm GB, Crippin JS, et al. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. HEPATOLOGY 1997;25:672-677.
8. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol 1983; 11:710-719.
9. Evans RW, Manninnen DL, Dong FB. An economic analysis of liver transplantation. Costs, insurance coverage, and reimbursement. Gastroenterol Clin North Am 1993;22:451-473.
10. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. HEPATOLOGY 1989;10:l-7.
11. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, et al. Primary sclerosing cholangitis: Refinement and validation of survival models. Gastroemerology 1992;103:1893-1901.
12. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989;321:1092-1099.
13. Belzer FO, D'Alessandro AM, Hoffmann RM, et al. The use of UW solution in clinical transplantation: a four-year experience. Ann Surg 1992;215:579-583.
14. Shaw BW, Gordon RD, Iwatsuki S, Starzl TE. Hepatic retransplantation. Transplant Proc 1985;17:264-271..
15. Anthuber M, Pratschke E, Jauch KW, Zuelke C, Groh J, Weite M, Forst H. Liver retransplanatation-indications, frequencies, results. Transplant Proc 1992;24:1965-1996.
16. Lemmens HP, Tsiblakis N, Langrehr JM, Blumhardt G, Lohmann R, Keck H, Neuhaus P. Comparison of perioperative morbidity following primary liver transplantation and liver retransplantation. Transplant Proc 1993; 25:1923-1924.
17. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplanatation 1993;55: 807-813.
18. Fangmann J, Ringe B, Hauss J, Pichlmayr R. Hepatic retransplantation: the Hannover experience of two decades. Transplant Proc 1993;25:1077-1078.
19. Mora NP, Klintmalm GB, Gofer JB, Poplawski SS, Goldstein RM, Gonwa TA, Husberg BS. Results after liver transplantation: a comparative study between "elective" vs "nonelective" retransplantation. Transplant Proc 1990;22:1509-1511.
20. Pappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Path 1995;19:192-206.
21. Doyle HR, Morelli F, McMichael J, Doria C, Aldrighetti L, Starzl TE, Marino IR. Hepatic retransplantation - an analysis of risk factors associated with outcome. Transplantation 1996;61:H99-1505.
22. Kamath GS, Plevak DJ, Wiesner RH, et al. Primary nonfunction of the liver graft: when should we rtransplant? Transplant Proc 1991;23:1954.
23. Doyle HR, Marino IR, Jabbour N, Zetti G, McMichael J, Mitchell S, Fung J, et al. Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation 1994;57: 1028-1036.
24. Evans RW, Manninen DL, Dong FB, McLynne DA. Is retransplantation cost effective? Transplant Proc 1993;25:1694-1696.